{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:49:56Z","timestamp":1781880596324,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Peritoneal tuberculosis is the most common cause of low albumin gradient ascites in developing countries, but it can be easily confused with other causes of ascites. Peritoneal tuberculosis requires early recognition of symptoms and signs in order to make a quick diagnosis for appropriate treatment<jats:bold>.<\/jats:bold> Measurement of adenosine deaminase (ADA) level\u2009&gt;\u200939 in ascites fluid is an established test to diagnose peritoneal tuberculosis. Many low-income countries do not currently test for adenosine deaminase in ascites fluid, including Rwanda.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Cross-sectional, descriptive study conducted through the Internal Medicine Department of three university teaching hospitals in Rwanda. Participants were patients older than 16\u2009years presenting to tertiary referral hospitals with ascites of unknown cause.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 103 ascites fluid samples collected, 52 of them (50.5%) had an elevated ADA, consistent with a presumptive diagnosis of peritoneal TB. Among those 52 subjects diagnosed with peritoneal TB, 39 out of 52 (75%) did not receive anti-TB medications. Among the 17 subjects who were treated with anti-TB medications, 4 of 17 (23.6%) did not have peritoneal TB based on ADA level. Samples with low-albumin gradient ascites were more likely to have high ADA \u226539\u2009IU\/L (<jats:italic>p<\/jats:italic>\u2009=\u20090.039).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings suggest that 3out of 4 patients with PTB in Rwanda are not getting TB treatment and 1 in 4 patients who are taking TB medications do not need it. Even if the true number of Rwandans who are being undertreated and overtreated is less than our study suggests, these results should prompt a larger study of peritoneal tuberculosis. Adding adenosine deaminase (ADA) to the diagnostic tools available to clinicians could help achieve the goal of correctly putting every Rwandan with tuberculosis on treatment, while avoiding unnecessary tuberculosis medications in those who do not have the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-04965-0","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T13:03:00Z","timestamp":1584709380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of adenosine deaminase (ADA) to diagnose suspected peritoneal tuberculosis in Rwanda: a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"given":"Jules","family":"Ntwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dusabejambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"4965_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.dld.2003.10.016","volume":"36","author":"E Vardareli","year":"2004","unstructured":"Vardareli E, Kebapci M, Saricam T, Pasaoglu O, A\u00e7ikalin M. Tuberculous peritonitis of the wet ascitic type: clinical features and diagnostic value of image-guided peritoneal biopsy. Dig Liver Dis. 2004;36:199\u2013204.","journal-title":"Dig Liver Dis"},{"key":"4965_CR2","unstructured":"World Health Organization \" Global Tuberculosis Report 2017\". https:\/\/www.who.int\/tb\/publications\/global_report\/gtbr2017."},{"key":"4965_CR3","unstructured":"Biziyaremye FL, Afrika FR, Byukusenge FR, et al. Tuberculosis and other respiratory communicable diseases control. Rwanda Biomed Center Ann Rep. 2015:1\u20136."},{"key":"4965_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00004836-200609000-00009","volume":"40","author":"AM Riquelme","year":"2006","unstructured":"Riquelme AM, et al. Value of adenosine Deaminase in Ascitic fluid for the diagnosis of Tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol. 2006;40:705\u201310.","journal-title":"J Clin Gastroenterol"},{"key":"4965_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1378\/chest.99.5.1134","volume":"99","author":"JB Mehta","year":"1991","unstructured":"Mehta JB, Dutt A, et al. Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest. 1991;99:1134\u20138.","journal-title":"Chest"},{"key":"4965_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1086\/341898","volume":"35","author":"KM Chow","year":"2002","unstructured":"Chow KM, Chow VC, et al. Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples. Clin Infect Dis. 2002;35:409.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4965_CR7","first-page":"111","volume":"27","author":"L Boonyagars","year":"2010","unstructured":"Boonyagars L, Kiertiburanakul S. Use of adenosine Deaminase for the diagnosis of tuberculosis: a review. J Infect Dis Antimicrob Agents. 2010;27(2):111\u20138.","journal-title":"J Infect Dis Antimicrob Agents"},{"key":"4965_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/s-0028-1085700","volume":"29","author":"K L\u00f6nnroth","year":"2008","unstructured":"L\u00f6nnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Resp Crit Care Med. 2008;29:481.","journal-title":"Semin Resp Crit Care Med"},{"key":"4965_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1099\/jmm.0.035121-0","volume":"61","author":"A Mohammad","year":"2012","unstructured":"Mohammad A, Hammad E, et al. Use of adenosine deaminase measurements and QuantiFERON in the rapid diagnosis of tuberculous peritonitis. J Med Micro. 2012;61:514\u20139.","journal-title":"J Med Micro"},{"issue":"22","key":"4965_CR10","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.3748\/wjg.v18.i22.2837","volume":"18","author":"SJ Kang","year":"2012","unstructured":"Kang SJ, Kim JW, et al. Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis. World J Gastroenterol. 2012;18(22):2837\u201343.","journal-title":"World J Gastroenterol"},{"key":"4965_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1054\/tube.2001.0289","volume":"81","author":"LJ Burgess","year":"2001","unstructured":"Burgess LJ, Swanepoel CG, et al. The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis. Tuberculosis. 2001;81:243\u20138.","journal-title":"Tuberculosis"},{"key":"4965_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-2007-1010551","volume":"24","author":"M Mimica","year":"1992","unstructured":"Mimica M. The usefulness and limitations of laparoscopy in the diagnosis of tuberculous peritonitis. Endoscopy. 1992;24:588\u201391.","journal-title":"Endoscopy"},{"key":"4965_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/003655201750153412","volume":"5","author":"M Muneef","year":"2001","unstructured":"Muneef M, Memish Z, et al. Tuberculosis in the belly: a review of forty-six cases involving the gastrointestinal tract and peritoneum. Scand J Gastroenterol. 2001;5:528\u201332.","journal-title":"Scand J Gastroenterol"},{"key":"4965_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9343(97)89456-9","volume":"100","author":"AO Shakil","year":"1996","unstructured":"Shakil AO, Korula J, et al. Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med. 1996;100:179\u201385.","journal-title":"Am J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-04965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-04965-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-04965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:16:45Z","timestamp":1616199405000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-04965-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4965"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-04965-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]},"assertion":[{"value":"16 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants in this study provided a written consent to participate to the study, after explanation of the risks and benefits of participation of this study. For patient who was very sick and unable to sign consent, the next of kin was the one to sign consent from on this behalf. All kind of information provided by participant was kept in strict confidentiality.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Jules Ntwari declares that he has no competing interest. He has received no payments from any pharmaceutical or medical device company.Dr. Cameron Page declares that he has no competing interest. He has received no payments from any pharmaceutical or medical device company.Dr. Vincent Dusabejambo declares that he has no competing interest. He has received no payments from any pharmaceutical or medical device company.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}